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 1 
COMMERCIAL DECEPTION BY ANTI-VACCINE HOMEOPATHIC 
WEBSITES: A CONSUMER PROTECTION APPROACH 
DONALD C. ARTHUR1 
Abstract 
Some internet marketers offer for sale “vaccination substitutes” that can 
purportedly replace actual scientifically-tested and federally-approved vac-
cinations. Deceptive internet advertising for vaccine substitutes has dis-
suaded parents from vaccinating their children, resulting in a resurgence of 
vaccine-preventable childhood diseases. The Food and Drug Administration 
and Federal Trade Commission have the authority to address dangerously 
deceptive product claims, including those for homeopathic preparations that 
have thus far avoided safety and efficacy testing. This article presents the 
issues involved in deceptive advertising and proposes regulatory solutions. 
Prologue: “I’m sorry... she’s gone.” 
Childhood vaccines are one of the great triumphs of modern medicine. 
Indeed, parents whose children are vaccinated no longer have to worry 
about their child’s death or disability from whooping cough, polio, diphthe-
ria, hepatitis, or a host of other infections.2 
My entire life changed the moment I first held Kaliah. Gazing at me with 
her big brown eyes, as I touched her thick brown hair, I couldn’t put her 
down. She was absolutely gorgeous. 
Then I got a phone call from the health department telling me Kaliah and 
I were both positive for whooping cough. I was in shock. How could this 
happen? The next day her cough got worse and she was hospitalized. They 
had to keep increasing her dosage of oxygen as she weakened. On day five, 
she stopped breathing. Kaliah was in an incubator with wires on her, an IV 
in her wrist, and a ventilator tube in her mouth. It was heartbreaking to see 
my little baby girl in so much pain. 
                                                                                                                             
 1. The author is a 2017 Juris Doctor candidate at the University of Massachusetts School of Law. 
He is an emergency medicine and preventive medicine physician who served 33 years in the U.S. Navy, 
culminating his career as the Navy Surgeon General, retiring at the rank of Vice Admiral. He has been 
chief executive officer of three hospitals, including the National Naval Medical Center in Bethesda, 
Maryland. 
 2. Ezekiel J. Emanuel, How We Can Save Over 4 Million Children, THE HUFFINGTON POST (Oct. 
7, 2010), http://www.huffingtonpost.com/zeke-emanuel/post1029b755048.html 
[https://perma.cc/3URQ-C7K8]. 
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All of a sudden, Kaliah started twitching. We were watching our three 
and a half week old baby have a seizure. The next morning, she had another 
seizure. 
The doctor brought up the ECMO3 machine and told me that if things got 
worse it was our last option. No one had told me Kaliah might not make it! 
She had a very low oxygen level and this was life support—our very last 
option. Everything was getting worse fast. She was so swollen that I could 
barely recognize her. Her body was purple from all the blood and medicines 
leaking from her veins. It was so hard to see her that way. I tried my hardest 
to stay strong for her. I kept telling her I loved her, that everything was go-
ing to be alright. 
Four doctors came out to talk to us. ”There is nothing more we can do to 
help her, she’s too sick. We are so very sorry.” Everyone in the room was 
crying including all the doctors. We watched the doctor take her off life 
support. Kaliah gasped for her last breath. We sat there and watched our 
little girl go. The doctor came in and checked for a heart beat and said, “I’m 
sorry... she’s gone.”4 
This true vignette captures the horror of a single childhood death from a 
disease that is completely preventable by a recommended and safe vaccina-
tion given during pregnancy. 
I. Introduction 
“It shall be unlawful . . . to disseminate, or cause to be disseminated, any 
false advertisement . . . likely to induce, directly or indirectly the purchase 
of food, drugs, devices, services, or cosmetics.”5 
Knowingly false information published on internet websites that misleads 
consumers about the effectiveness of alternative medicine products and 
dissuades consumers from obtaining safe and effective immunizations6 for 
their children is a matter of serious public concern. 
In the 220 years since the first vaccine was developed, dozens of safe and 
effective vaccines have been produced to protect against feared diseases. A 
                                                                                                                             
 3. Extra-Corporeal Membrane Oxygenation. When a patient’s lungs are too diseased to breathe, 
ECMO is a process by which a patient’s blood is enriched with oxygen by a machine rather than through 
the patient’s lungs. Heather Carriedo & Douglas Deming, Therapeutic Techniques: Neonatal ECMO, 4 
NEOREVIEWS e212, e212 (2003). 
 4. Chelsey Charles, Kaliah’s Story, SHOTBYSHOT.ORG, http://shotbyshot.org/pertussis/kaliahs-
story/ [https://perma.cc/X44D-SYK3] (last visited Mar. 18, 2016) (adapted with permission); see also 
Betty Ann Bowser, Whooping Cough Can Kill: One Mother’s Story of Loss, PBS NEWSHOUR (Au-
gust 22, 2012), http://www.pbs.org/newshour/rundown/losing-a-baby-to-whooping-cough-one-mothers-
story-1/ [https://perma.cc/73Z7-AB5C]. 
 5. 15 U.S.C. § 52 (2011). 
 6. In this Note, “immunize” and “immunization” have the same meanings and are used inter-
changeably with “vaccinate” and “vaccination,” respectively. Likewise, the terms “disease” and “ill-
ness” are used as synonyms. 
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sequence of childhood immunizations now shields children from vaccine-
preventable illnesses, many of which have nearly disappeared in the U.S. as 
a result. However, recent unfounded skepticism about vaccine safety and 
effectiveness has caused some parents to avoid vaccinating their children, 
and the impact has been a resurgence of previously controlled vaccine-
preventable illnesses. 
Some internet marketers have taken advantage of this skepticism to de-
ceptively advertise pharmacologically inert products as vaccine substitutes. 
Advertisers present false and misleading information about the claimed 
dangers of vaccination. This practice not only predictably induces consum-
ers to purchase alternate products but also dissuades consumers from 
providing protective vaccines to their children. 
Deceptive advertising is prominent on websites that offer homeopathic 
preparations as vaccine substitutes. Homeopathic preparations contain no 
medically active ingredients—they contain only water that homeopathic 
practitioners claim has a “memory” for a substance with which the water 
was once in contact.7 Homeopaths claim that the water’s “memory” pro-
duces medicinal effects in ways medical and research communities are una-
ble to scientifically detect and are biologically implausible.8 
Inexplicably, the Food and Drug Administration (FDA) Compliance Pol-
icy Guide, Section 400.400, exempts all homeopathic preparations from 
safety and effectiveness requirements imposed on all other over-the-counter 
preparations. Although the Federal Trade Commission (FTC)—that regu-
lates the advertising of over-the-counter preparations—requires proof of a 
product’s safety and effectiveness, homeopathic products do not need to 
meet this requirement because they contain no medically active ingredients. 
This dichotomy allows the homeopathic industry to claim their products 
have health effects (the water “memory”) while also being inert, thereby 
avoiding both FDA and FTC scrutiny. 
This enormous loophole threatens public health and should be closed. To 
do so, the FDA should repeal the Compliance Policy Guide that shields 
homeopathic manufacturers from requirements to demonstrate their prod-
ucts are safe and effective. The FTC should apply its health product safety 
and efficacy requirements uniformly, to include homeopathic products. The 
FTC should also address the proliferation of deceptive advertising intended 
to turn parents away from immunizing their children against vaccine-
preventable diseases and, thereby, eroding public health. 
                                                                                                                             
 7. CHRISTINE ADAMS, HOMEOPATHIC MEDICINE: THE COMPLETE GUIDE TO HOMEOPATHIC 
MEDICINE AND TREATMENT OF COMMONS DISORDERS 11 (2014). 
 8. Klaus Linde et al., Are the Clinical Effects of Homoeopathy Placebo Effects? A Meta-Analysis 
of Placebo-Controlled Trials 350 THE LANCET 834, 834 (1997). 
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Section II discusses vaccine benefits and the impact of withholding 
childhood immunizations. Section III presents the history and causes for 
vaccine skepticism and why people cherish impossible beliefs despite 
overwhelming contrary evidence. In section IV, the role of the internet in 
consumer fraud is discussed. Section V presents the landscape of FDA and 
FTC regulatory options, and Section VI proposes a practical roadmap of 
solutions. Section VII concludes. 
II. The Benefits of Vaccines 
A. Vaccines’ Profound Effect on Many Feared Childhood Illnesses 
The development of vaccines has been called “one of the brightest chap-
ters in the history of science”9 and a “turning point in the war between mi-
crobes and humans.”10 In 1796, Dr. Edward Jenner developed a vaccine that 
protected against smallpox.11 In the late nineteenth century, vaccines were 
developed for rabies, cholera, and plague.12 Safe and effective vaccines are 
now available to protect against diphtheria, Haemophilus influenza type b, 
hepatitis A, hepatitis B, human papilloma virus, measles, meningococcal 
disease (meningitis), mumps, pertussis (whooping cough), pneumococcal 
diseases, poliomyelitis, rotavirus, rubella (German measles), seasonal influ-
enza, tetanus, and varicella (chickenpox).13 Although administered only to 
select populations, vaccines are also available for anthrax, cholera, Herpes 
zoster, Japanese encephalitis, Lyme disease, plague, rabies, smallpox, tick-
borne encephalitis, typhoid, and yellow fever.14 
People can develop immunity to many illnesses by contracting and suf-
fering through the illness, which creates a natural or “primary” immunity 
because the body’s immune system remembers the offending virus or bacte-
rium by creating antibodies.15 Once a person survives an initial infection, 
the antibodies produced as a result will quickly mount a defensive response 
to subsequent infections, repelling the infection and preventing a subse-
quent clinical illness.16 However, developing antibodies in this way risks 
exposure to the serious and often debilitating or life-threatening effects of 
these illnesses during an infection. 
                                                                                                                             
 9. Stanley Plotkin, History of Vaccination, 111 PROC. NAT’L ACAD. SCI. 12283, 12283 (2014). 
 10. Bali Pulendran & Rafi Ahmed, Immunological Mechanisms of Vaccination, 12 NAT. 
IMMUNOL. 509, 509 (2011). 
 11. Stefan Riedel, Edward Jenner and the History of Smallpox and Vaccination, 18 BAYLOR U. 
MED. CTR. PROC. 21, 24 (2005). 
 12. Plotkin, supra note 9, at 12284. 
 13. Anne Schuchat & Lisa A. Jackson, Immunization Principles and Vaccine Use, in HARRISON’S 
PRINCIPLES OF INTERNAL MEDICINE, 785, 787 (Dennis L. Kasper et al. eds., 19th ed. 2015). 
 14. Plotkin, supra note 9, at 12284. 
 15. See generally Peter Delves & Ivan Roitt, The Immune System, 343 NEW ENGL. J. MED. 37 
(2000). 
 16. Id. 
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Vaccines have been developed to safely introduce non-disease producing 
components of viruses and bacteria to a person’s immune system, causing 
the immune system to develop antibodies to the viral or bacterial compo-
nents.17 Thereafter, the antibodies will react to a subsequent exposure as if 
the antibodies had been produced by a natural infection, thereby preventing 
infection and clinical illness.18 However, this method, called secondary 
immunity, may not last as long as primary immunity, obtained after being 
infected with the disease, leaving some individuals susceptible to infec-
tion.19 
“[V]accines represent the most cost-effective life-saving device in histo-
ry.”20 The prevalence of childhood and adult vaccine-preventable illnesses 
has been dramatically reduced. Smallpox has been eradicated worldwide; 
polio has been eliminated in the U.S. (and most other nations); and diphthe-
ria, measles, mumps, rubella, Haemophilus influenza, and hepatitis A cases 
have been reduced by more than 98% in the United States.21 Other signifi-
cant advances include a 95% reduction in varicella (chicken pox), a 94% 
reduction in tetanus, and a 76% reduction in pertussis (whooping cough) in 
the United States.22 
B. Reduced Vaccination Rates and the Resurgence of Vaccine-
Preventable Illnesses 
While vaccines are not 100% effective, people have an increased level of 
protection against vaccine-preventable illnesses than ever before. (Consider 
re-writing this sentence to flow better) The Centers for Disease Control and 
Prevention (CDC) have documented “[d]ramatic declines in morbidity . . . 
for the [then] nine vaccine-preventable diseases for which vaccination was 
universally recommended in children.”23 
Nevertheless, there has been a resurgence of vaccine-preventable illness-
es due to public skepticism about vaccine effectiveness and the incidence of 
claimed but unsubstantiated adverse effects of vaccines. Except for the 
world-wide eradication of smallpox and the near eradication of polio, many 
                                                                                                                             
 17. Id. 
 18. Id. 
 19. Id. 
 20. Pulendran, supra note 10, at 509. 
 21. Anne Schuchat & Lisa A. Jackson, Immunization Principles and Vaccine Use, in HARRISON’S 
PRINCIPLES OF INTERNAL MEDICINE, 785, 785 (Dennis L. Kasper et al. eds., 19th ed. 2015). 
 22. Id. 
 23. Centers for Disease Control and Prevention, Achievements in Public Health, 1900-1999 Impact 
of Vaccines Universally Recommended for Children -- United States, 1990-1998, 48 MORBIDITY AND 
MORTALITY WEEKLY REPORT 243, 243-48 (1999). The nine vaccine preventable diseases mentioned are 
smallpox, diphtheria, pertussis, tetanus, polio, measles, mumps, rubella, Haemophilus influenza type b. 
Id. 
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infectious diseases persist, and the threat of their morbidity,24 mortality,25 
and lifetime effects remains.26 
The incidence of many vaccine-preventable illnesses is increasing, rather 
than decreasing or being eliminated altogether. For example, “measles was 
declared eliminated from the United States” in 2000, yet over 1,400 recent 
cases have been documented and, of those, 57% were in unvaccinated indi-
viduals.27 Seventy percent of those who were unvaccinated had non-
medical exemptions.28 In addition, unvaccinated individuals were more 
likely to be the index (first) case, and to be cases in the next generation of 
cases (spread from the index case) than those who were vaccinated.29 
Alarmingly, unvaccinated individuals had a thirty-five times greater risk of 
acquiring a measles infection than vaccinated individuals.30 
Mumps was considered totally eliminated in the U.S. by 2010 after a se-
cond “booster” vaccination was recommendation in 1990.31 However, 
mumps has reemerged in unvaccinated individuals, causing great concern 
among public health officials.32 Similarly, vaccine use had reduced the in-
cidence of pertussis (whooping cough) to just one case in 100,000 people.33 
In the past decade, however, the incidence has increased to nine cases in 
100,000 people.34 
Similarly, in 32 pertussis outbreaks totaling 10,609 cases, between 59% 
and 93% of cases occurred in intentionally unvaccinated individuals.35 
Generally, higher rates of pertussis occur in communities with higher rates 
of vaccination refusal.36 
Comparable recent findings in other vaccine-preventable illnesses have 
motivated research into the factors involved in the trend toward vaccine 
                                                                                                                             
 24. “Morbidity” refers to the adverse effects of a disease. Diffen, Morbidity vs. Mortality, 
DIFFEN.COM, http://www.diffen.com/difference/Morbidity_vs_Mortality [https://perma.cc/AP4N-
V2QK] (last visited Mar. 22, 2016). 
 25. “Mortality” refers to deaths caused by a disease. Id. 
 26. Schuchat, Supra note 21, at 785. 
 27. Varun Phadke, et al., Association Between Vaccine Refusal and Vaccine-Preventable Diseases 
in the United States—A Review of Measles and Pertussis, 315 J. Am. Med. Ass’n 1149, 1154 (2016) 
(reviewing 50 published studies of recent measles and pertussis outbreaks). 
 28. Id. at 1154. 
 29. Id. 
 30. Id. 
 31. Gustavo Dayan et al., Recent Resurgence of Mumps in the United States, 385 NEW ENGL. J. 
MED. 1580, 1580-82 (2008). 
 32. Id. at 1583. 
 33. James Cherry, Epidemic Pertussis in 2012 – The Resurgence of a Vaccine Preventable Dis-
ease, 367 NEW ENGL. J. MED. 785, 785 (2012). 
 34. Id. at 785-86. 
 35. Phadke, supra note 27, at 1154. 
 36. Id. 
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refusal by the parents of healthy children. The following sections will dis-
cuss these factors as consumer health issues. 
III. Fraud Sways Public Sentiment Away From Vaccination 
A. The Painful Lesson of the Autism Hoax 
In 1998, Andrew Wakefield, a former British physician, published an ar-
ticle in the medical journal, The Lancet, implying there was a causal link 
between the measles-mumps-rubella (MMR) vaccine and development of 
autism in some of the twelve children he studied who received the vac-
cine.37 In a press conference, Dr. Wakefield publicly condemned the MMR 
vaccine and encouraged parents to refuse the vaccination.38 This article 
started a world-wide campaign by an empowered anti-vaccine movement to 
brand not only the MMR vaccine but all vaccines as suspect, and encour-
aged parents to avoid vaccinating their children for fear of developing au-
tism and other neurological developmental disorders.39 
But Dr. Wakefield’s research was a fraud—a hoax intended to allow his 
own newly patented vaccine to be sold as a “safer measles shot” in the 
wake of the public’s fear of the MMR vaccine.40 Additionally, Wakefield 
had been paid by a solicitor to develop a research paper that would show a 
link between autism and a particular manufacturer’s vaccine; the paper was 
to be used in product liability litigation against the manufacturer.41 
As a result of a series of independent investigations and discovery of re-
search fraud, The Lancet partially retracted Wakefield’s article in 200442 
and fully retracted it in 2010.43 
In 2010, Wakefield’s license to practice medicine was revoked by the 
General Medical Council for “serious professional misconduct.”44 The 
Council “concluded that it is the only sanction that is appropriate to protect 
patients and is in the wider public interest, including the maintenance of 
public trust and confidence in the profession and is proportionate to the 
serious and wide-ranging findings made against him.”45 
                                                                                                                             
 37. A. J. Wakefield et al., Ileal-Lymphoid Hyperplasia, Non-Specific Colitis, and Pervasive De-
velopmental Disorder in Children, 351 THE LANCET 637 (1998). 
 38. SETH MNOOKIN, The Lancet Paper, in THE PANIC VIRUS 107-08 (2011). 
 39. Id. 
 40. Brian Deer, How the Case Against the MMR Vaccine Was Fixed, 342 BRIT. MED. J. 77, 77 
(2011). 
 41. Brian Deer, How the Vaccine Crisis was Meant to Make Money, 342 BRIT. MED. J. 136, 137 
(2011). 
 42. Simon H. Murch et al., Retraction of an Interpretation, 363 THE LANCET 750, 750 (2004). 
 43. The Editors of The Lancet, Retraction—Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific 
Colitis, and Pervasive Developmental Disorder in Children, 375 THE LANCET 445, 445 (2010). 
 44. Fitness to Practice Panel Report, GENERAL MEDICAL COUNCIL (May 24, 2010), 
https://jdc325.files.wordpress.com/2010/05/andrew-wakefield-struck-off-gmc.pdf 
[http://perma.cc/7TC7-CEAK]. 
 45. Id. 
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Nevertheless, public confidence in the MMR vaccine specifically and 
vaccinations generally had been severely shaken. To find the truth of the 
matter and restore public confidence, the scientific community intensely 
studied the MMR vaccine and its purported link to autism. Over the suc-
ceeding fifteen years, more than 1,100 peer-reviewed studies were pub-
lished.46 The most comprehensive review included a meta-analysis of re-
search that studied 1,256,407 children and found “no evidence of a relation-
ship between vaccination and autism or autism spectrum disorders, and as 
such advocate[d] the continuation of immunisation [sic] programs accord-
ing to national guidelines.”47 
However, public confidence was not restored. Notwithstanding the 
weight of scientific evidence, the “rising awareness of autism incidence, 
prevalence, and the postulated causation by childhood vaccinations . . . led 
to both an increased distrust in the trade-off between vaccine benefit out-
weighing potential risks and an opportunity for disease resurgence.”48 De-
spite the fraudulent nature of the since-retracted Lancet publication, the 
anti-vaccine movement accelerated even in the face of years of scientific 
study and the consensus of the scientific community. Paradoxically, it 
seemed that, rather than bolster public confidence in vaccines, the univer-
sally supportive research had the perverse effect of diminishing the public’s 
confidence in the scientific community and generating suspicion that physi-
cians and researchers supported vaccine manufacturers only for economic 
benefit.49 
B. The Dunning-Kruger Effect and Homeopathy 
Cornell research psychologists David Dunning and Justin Kruger mod-
eled the psychological basis for an obstinate belief in an impossible, illogi-
cal, or disproven idea. Their research—and the Dunning-Kruger Effect that 
bears its name—describes a person’s inability to appreciate the falsity of a 
deeply held belief despite overwhelming evidence of its falseness and to 
incorrectly ascribe a causative correlation to independent events that occur 
simultaneously.50 Further, as more evidence is accumulated to disprove the 
                                                                                                                             
 46. Luke E. Taylor et al., Vaccines are Not Associated with Autism: An Evidence-Based Meta-
Analysis of Case-Control and Cohort Studies, 32 VACCINE 3623, 3625 (2014). 
 47. Id. at 3625, 3628 (“This meta-analysis aims to quantitatively assess the available data from 
studies undertaken in various countries regarding autism rates and childhood vaccination so that the 
relationship between these two, whatever its significance, can be adequately substantiated.”). 
 48. Id. at 3623. 
 49. Sandra J. Bean, Emerging and Continuing Trends in Vaccine Opposition Website Content, 10 
VACCINE 1874, 1877 (2011). 
 50. Justin Kruger & David Dunning, Unskilled and Unaware of It: How Difficulties in Recogniz-
ing One’s Own Incompetence Lead to Inflated Self-Assessments, 77 J. PERSONALITY AND SOC. 
PSYCHOL. 1121, 1131 (1999). 
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belief, the more fervent some people’s beliefs in the falsity become, so they 
may believe multiple ideas that contradict each other.51 
One manifestation of the Dunning-Kruger Effect is the disbelief in scien-
tific proof in favor of a steadfast belief in the irrational and scientifically 
unsupported practice of homeopathy. Homeopathy was developed in the 
late eighteenth century when the average life expectancy in the U.S. was 35 
years, epidemics were commonplace, the nature of infection—”contagion” 
as it was called then—was unknown, and sanitation was lacking and unap-
preciated.52 Prevailing medical theories included malevolent humours53, 
yellow bile and black bile imbalance, and levels of body fluid acidity or 
alkalinity; treatment involved bleeding, purging, and sweating, but not bath-
ing because that was considered dangerous.54 
In this milieu, Samuel Hahnemann, the founder of homeopathy, contend-
ed that putting fluid from a diseased person into a solution, shaking it, and 
diluting it at least a sextillion (a billion trillion) times would allow the water 
with which it was diluted to retain a “memory” of the toxic material.55 
When so diluted, the resulting solution cannot possibly contain even a sin-
gle molecule of the original fluid. Yet, homeopathic practitioners claim 
these solutions, containing only water to which they may add coloring or 
flavoring, have special prophylactic and healing properties that cannot be 
detected by conventional scientific means.56 Homeopathic practitioners 
claim the individual water molecules retain a “memory” of the diluted sub-
stance but, inexplicably, not the memory of any other substance with which 
the water molecules have ever come into contact.57 
Medical researchers at the National Institutes of Health have “found in-
sufficient evidence from [hundreds of] studies that homeopathy is clearly 
efficacious for any single clinical condition.”58 One author concluded ho-
meopathy was “at the extreme absurd end of the silly pseudoscience spec-
trum, even among some stiff competition.”59 
                                                                                                                             
 51. LEON FESTINGER ET AL., WHEN PROPHESY FAILS 3 (2008). 
 52. C. KEITH WILBUR, REVOLUTIONARY MEDICINE: 1700-1800 (1980). 
 53. “Humoral theory, also known as humorism or the theory of the four humours, was a model for 
the workings of the human body. . . . In this theory, humours existed as liquids within the body and were 
identified as blood, phlegm, black bile and yellow bile. A good balance between the four humours was 
[thought to be] essential to retain a healthy body and mind, as imbalance [was thought to] result in 
disease. “ Science Museu, Humors, 
http://www.sciencemuseum.org.uk/broughttolife/techniques/humours [https://perma.cc/N6MN-ZJTF] 
(last viewed Feb 9, 2017). 
 54. Id. 
 55. Adams, supra  note 7, at 11. 
 56. Linde, supra note 8, at 834. 
 57. Id. 
 58. Id. 
 59. Steven Novella, Homeopathic Thuggery, SCIENCE-BASED MEDICINE (Aug. 17, 2011), 
https://www.sciencebasedmedicine.org/homeopathic-thuggery/ [https://perma.cc/HF9H-LREF]. 
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Nevertheless, scientifically unsophisticated or gullible members of the 
public have eschewed vaccinations in favor of what they have come to be-
lieve is a more natural method of disease prevention—one that historically 
had no effect on the prevalence of vaccine-preventable diseases in the cen-
turies before the advent of vaccines. As a result, “one in ten [parents is] 
choosing not to give one or more vaccines [to their children]. Some aren’t 
giving any vaccines at all; since 1991, the percentage of unvaccinated chil-
dren has more than doubled.”60 The decrease in vaccination rates and con-
sequent resurgence of vaccine-preventable childhood illnesses due to “un-
warranted fear and speculation threatens children” and poses a great public 
health threat.61 This threat is avoidable. 
C. The Homeopathy Paradox 
Homeopathic practitioners argue both sides of the regulatory issue. On 
the one hand, they argue that homeopathic potions are not medicinal and, 
therefore, should not be clinically tested or regulated. Correctly stating that 
homeopathic brews contain not a single molecule of an active ingredient 
and are, therefore, only water with flavoring or coloring, allows homeo-
paths to argue against clinical testing for efficacy and safety because the 
potions have no pharmacologically active ingredient. 
On the other hand, they also claim the water has a “memory” of the ac-
tive ingredient and this property somehow conveys medicinal value to the 
solution. If accepted, this claim of pharmacologic activity would require the 
same substantiation as all other medicinal preparations. 
There is, however, a third possibility—one that homeopathic practition-
ers are averse to considering. In cases where homeopathic preparations are 
subjectively effective, the therapeutic activity could be attributed to mere 
chance or a placebo effect as borne out by scientific studies.62 The effect 
would be attributed solely to the consumer’s faith, conferring on homeopa-
thy a label of entertainment or mystical belief. This alternative would be 
unpalatable to homeopathic practitioners because a spiritual mechanism 
would not allow homeopaths to market their products as having profitable 
health enhancing properties. 
Claiming medicinal properties and presenting homeopathic preparations 
as substitutes for vaccinations creates a public health menace that should be 
addressed by the FTC through enforcement of its prohibition against decep-
                                                                                                                             
 60. PAUL A. OFFITT, Prologue to DEADLY CHOICES—HOW THE ANTI-VACCINE MOVEMENT 
THREATENS US ALL, at xv (2011). 
 61. Emily C. de los Reyes, Autism and Immunizations, 67 ARCH. NEUROL. 490, 491 (2010). 
 62. National Health and Medical Research Council, Information Paper: Evidence on the Effective-
ness of Homeopathy for Treating Health Conditions (March 2015), [https://perma.cc/3TQW-Y6BF] 
(finding “there are no health conditions for which there is reliable evidence that homeopathy is effec-
tive.”). 
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tive advertising and by the FDA through their mandate to ensure medicinal 
products are safe and effective. 
IV. The Internet as a Venue for Consumer Fraud 
The internet is ubiquitous in America. Like radio, television, newspapers, 
and billboards, the internet has become a marketplace where advertisements 
are used to hawk goods for sale to a waiting online public market. The in-
ternet can also be a means to mislead unsuspecting, unsophisticated, or gul-
lible consumers. 
Unscrupulous marketers have used the public’s newly formed distrust of 
vaccines to turn that sentiment into opportunities to sell alternative prod-
ucts. Vaccine antagonists create believability by asserting that scientifical-
ly-refuted claims are nonetheless possible Often, they ascribe purported 
adverse effects to nebulous and unfounded vaccine-produced immune sys-
tem corruption and the unassociated temporal relationship of vaccine ad-
ministration to development of a condition.63 Autism, for example, is usual-
ly diagnosed at the same age that children receive several vaccinations, 
causing parents to intuitively—but incorrectly—associate the two events.64 
By contending vaccines are “ineffective, useless, or even dangerous,” 
some internet marketers encourage parents to forgo vaccinations in favor of 
highly profitable alternative commercial products that offer no protective 
value.65 Although the homeopathic products themselves are not inherently 
dangerous, ,their use in place of of vaccinations cause children  to remain 
vulnerable to vaccine-preventable illnesses. 
Internet marketers use a variety of methods to entice consumers to pur-
chase their products in lieu of vaccinations. They skew scientific evidence 
by presenting discredited, biased, or poorly constructed studies that present 
rare adverse effects as the norm or dramatize normal, minor and mild side 
effects.66 While claiming objectivity, marketers selectively exclude infor-
mation that demonstrates vaccine efficacy and safety.67 They use emotion-
ally-charged personal vignettes to highlight adverse events that may not be 
related in any way to vaccines.68 With no scientific background, self-
proclaimed experts are hailed as whistleblowers who are exposing wide-
spread fraud in the scientific community.69 Marketers claim vaccines are 
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 66. Id. at 3782. 
 67. Id. 
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toxic and should be 100% safe before being given to children.70 Marketers 
label vaccines “unnatural” and claim that permanent and debilitating ad-
verse effects are likely consequences of vaccination.71 
Celebrities such as Jenny McCarthy present the public face of parental 
testimony and, for some, lend legitimacy to marketers’ claims of vaccine 
dangers.72 Marketers often claim a child’s immune system is not developed 
enough to “cope” with the number and variety of vaccines being recom-
mended and may, in fact, be damaged as a result of receiving so many im-
mune system challenges—when exactly the opposite is true.73 A multi-
center study found that children of all ages “respond to multiple vaccines 
given at the same time in a manner similar to individual vaccines” and that: 
Current studies do not support the hypothesis that multiple vaccines 
overwhelm, weaken, or “use up” the immune system. On the contrary, 
young infants have an enormous capacity to respond to multiple vaccines, 
as well as to the many other challenges present in the environment. By 
providing protection against a number of bacterial and viral pathogens, vac-
cines prevent the “weakening” of the immune system and consequent sec-
ondary bacterial infections occasionally caused by natural infection.74 
Perhaps the most common and enticing mantra is the claim that vaccine 
proponents are “in the pocket of Big Pharma,” implying that the pharma-
ceutical industry has corrupted all those who would advocate vaccinations 
over alternate preventive methods such as homeopathy.75 Rather than ac-
cepting the recommendations of the American Academy of Pediatrics, the 
American Academy of Family Physicians, and the Centers for Disease Con-
trol and Prevention, parents are encouraged to make their own decisions, 
“informed by their own research” conducted on the internet.76 Deceptive 
marketers espouse alternative potions rather than vaccination as the best 
way to protect children.77 
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For example, on her Natural Solutions Foundation website, Rima Lai-
blow, MD (“Dr. Rima”), states in her petition to the Federal Trade Com-
mission (FTC) that: 
there is no significant scientific agreement or sufficient reliable and com-
petent scientific evidence from independent, unbiased sources to allow the 
conclusion that individual or multiple vaccinations, particularly of young 
children, provide any measurable public health care benefit. This is true 
whether the vaccinations are mandated or voluntary. Further, there is a 
large body of evidence which shows that repeated single and multiple vac-
cinations, especially in young children, can cause and has in fact caused 
devastating and irreparable harm to tens of thousands of the most vulnera-
ble citizens: our children.78 
The petition continues, stating a demand that the FTC “[i]ssue an imme-
diate Federal Trade Commission Emergency Order halting all Interstate 
Commerce regarding vaccines and vaccine related goods, until further order 
of the Commission.”79 
The Natural Solutions Foundation website links directly to the Natural 
Solutions Marketplace where “Dr. Rima recommends” visitors purchase a 
variety of dietary supplements, including a $299.97 one-ounce bottle of a 
hemp oil extract—a 30 day supply—to “support normal immune func-
tion.”80 At the Marketplace page, “Dr. Rima” posts a disclosure “under pro-
test” that says, “Please note that Nutrients and Supplements do not undergo 
FDA testing, nor are they ‘approved’ by the FDA which regulates only 
claims and labeling on these products.”81 “Dr. Rima” explains that she is 
required to post the disclosure but claims the requirement is “unconstitu-
tional compelled speech in violation of the First Amendment.”82 
While the majority of American parents would not likely be persuaded 
by internet misinformation to avoid vaccinating their children, enough par-
ents have been so influenced that the incidence of vaccine-preventable ill-
nesses has risen sufficiently to raise public health concerns.83 Playing to an 
unsophisticated public, marketers of homeopathic and other medically inert 
products cause public harm by increasing the incidence of otherwise pre-
ventable illnesses, causing morbidity in the affected children, and burden-
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ing the public health system with the costs of investigating and controlling 
outbreaks. 
V. An Unfair or Deceptive Act or Practice in or Affecting Com-
merce84 
Consumer protection laws can—and should—be employed to identify 
and remediate commercial internet sites that make false statements about 
the efficacy and safety of vaccinations. The recent decrease in vaccination 
rates and resultant increase in vaccine-preventable illnesses is a clear public 
health threat within the purview of the Federal Trade Commission (FTC) 
mission to “prevent business practices that are . . . deceptive or unfair to 
consumers . . .” and aligned with the FTC’s first strategic goal to “Protect 
Consumers: Prevent fraud, deception, and unfair business practices in the 
marketplace.”85 
Although the FTC has litigated instances of false and deceptive advertis-
ing of homeopathic remedies, it has yet to address the issue of those prac-
tices applied to vaccine substitutes. However, the Australian Competition 
and Consumer Commission—the Australian equivalent of the FTC—has 
successfully litigated just such a case. 
A. The Australian Experience with “Homeopathy Plus!” 
The Federal Court of Australia recently imposed injunctive relief and 
fines against a homeopathic website for publishing deceptive content.86 
Homeopathy Plus! is a commercial website where vaccines were misrepre-
sented, and alternatives for sale in the online store, were lauded as substi-
tutes.87 This case is the first in the world to directly address issues of decep-
tive advertising and misrepresentation of vaccine safety and efficacy on a 
commercial website. 
In December 2014, the Court held that Homeopathy Plus! made false and 
misleading statements about the whooping cough vaccine’s safety and ef-
fectiveness; ignored evidence-base medical research on the efficacy of the 
pertussis vaccine, calling the vaccine “unreliable at best”; and made false 
and misleading claims. The Court held that Homeopathy Plus! and its pro-
prietor claimed their homeopathic product was a vaccine substitute, and 
presented false and misleading information in the guise of public debate. 
Further, because Homeopathy Plus! and its proprietor displayed an ineffec-
                                                                                                                             
 84. 15 U.S.C. § 45(a)(1) (2012). 
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tive and deceptive disclaimer that did not “bring [Homeopathy Plus!’s] true 
position to the public’s attention” and published deceptive “expert” reports, 
the Court fined Homeopathy Plus! and its proprietor 138,000 AUD.88 I 
would give the equivalent of this in US currency. 
The arguments made during the Australian Competition and Consumer 
Commission litigation could serve as a template for similar FTC action in 
the U.S. 
B. Role of the Federal Trade Commission in Enforcing Advertising 
Standards 
The FDA and FTC share jurisdiction for regulating over-the-counter 
(OTC) health products. Under a 1971 Working Agreement between the two 
agencies, the FDA maintained jurisdiction over labeling issues and the FTC 
assumed jurisdiction over advertising issues.89 
The FTC Division of Advertising Practices enforcement priorities in-
clude “monitoring and stopping deceptive internet marketing practices that 
develop in response to public health issues.”90 The Division’s authority 
stems from sections 5 and 12 of the Federal Trade Commission Act.91 Sec-
tion 5 addresses advertising and labeling, and prohibits unfair or deceptive 
practices.92 Section 12 prohibits publication of false or deceptive adver-
tisement that affects food, drugs, devices, services, and cosmetics.93 For an 
advertisement to be misleading, Section 15 requires that “representations 
made or suggested” and “the extent to which the advertisement fails to re-
veal facts material . . . to the consequences” be considered in evaluating the 
advertisement in context.94 “A misleading claim or omission in advertising 
will violate Section 5 or Section 12 . . . if the omitted information would be 
a material factor in the consumer’s decision to purchase the product.”95 
Under the FDA Compliance Policy Guide (CPG), Section 400.400, ho-
meopathic health product labeling is treated with much less rigor than all 
other health products.96 Under the CPG, “[t]he Federal Food, Drug, and 
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Cosmetic Act (the Act) recognizes as official the drugs and standards in the 
Homeopathic Pharmacopeia of the United States and its supplements.”97 
Although the CPG requires product labeling and indications for use, the 
FDA does not impose any requirement that the products demonstrate either 
safety or effectiveness.98 Instead, the only mandate for a product to comply 
with the CPG is that the product be listed in the Homeopathic Pharmacope-
ia, a list that is generated and controlled by the homeopathic industry.99 
In contrast, the FTC’s standard for health products “bars representations 
about a product’s general health benefits ‘unless the representation is non-
misleading’ and backed by ‘competent and reliable scientific evidence that 
is sufficient in quality and quantity [to] substantiate that the representation 
is true.’”100 Additionally, the FTC Policy Statement Regarding Advertising 
Substantiation requires substantiation for advertising claims before they are 
published to consumers.101 Thus, despite the FDA’s lax compliance stand-
ard for homeopathic products, the FTC’s advertising standards require ho-
meopathic advertisers to demonstrate “competent and reliable scientific 
evidence” of product efficacy.102 
The regulatory dichotomy between the FDA and FTC standards allows 
marketers to label a product as homeopathic. This skirts the FDA’s re-
quirement for proof of efficacy required of all other products that claim 
health benefits, and shifts the burden of enforcement to the FTC where 
proof of efficacy is required. However, homeopathic marketers can also 
assert their products are non-medicinal to the FTC while claiming homeo-
pathic exemption based on the Homeopathic Pharmacopeia and ignoring 
the FDA’s efficacy standards. This double standard creates confusion for 
consumers and a loophole for homeopathic product manufacturers. 
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C. The FTC Policy Statement on Deception 
On October 14, 1983, the FTC issued a Policy Statement on Decep-
tion.103 According to the statement, the FTC will find an act or practice de-
ceptive if, “(1), there is a representation, omission, or practice that, (2), is 
likely to mislead consumers acting reasonably under the circumstances; and 
(3) the representation, omission, or practice is material.”104 
1. There must be “a representation, omission, or practice that is likely to 
mislead the consumer.”105 
In the case of internet commercial advertisements, deceptions are in writ-
ten form and may involve express misrepresentations as well as omission of 
information material to a consumer’s informed decision and that would 
otherwise prevent a representation from being misleading. In many cases, 
the misleading nature of an advertisement can be determined from the plain 
meaning of its statements, but external evidence may be requested where 
the exact meaning of the statements and their misleading nature may so 
require. 
Misleading statements are those that are expressly or impliedly contrary 
to facts. However, the misleading nature of statements need not be blatant 
but may, instead, be the result of a “juxtaposition of various phrases” that 
convey a misleading meaning to the reader.106 Consumers may also be mis-
led by the manner in which information is presented when the manner of 
presenting information belies the underlying commercial nature of the web-
site.107 
Omissions of material facts are deceptive when “qualifying information 
necessary to prevent a practice, claim, representation, or reasonable expec-
tation or belief from being misleading is not disclosed.”108 Further, 
“[o]missions may also be deceptive where the representations made are not 
literally misleading, if those representations create a reasonable expectation 
or belief among consumers that is misleading, absent the omitted disclo-
sure.”109 Moreover, “the practice of offering a product for sale creates an 
implied representation that it is fit for the purposes for which it is sold.”110 
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For example, consumers searching for information on vaccine choices 
can find HEALTHY.NET among the first few Google search results. On 
HEALTHY.NET (subtitled “healthy people, healthy planet”), “doctor” Randal 
Neustaedter provides a detailed, but misleading, explanation of how vac-
cines work, followed by a longer description of “Adverse Effects of Vac-
cines” (in bold text two times the font size of the surrounding text).111 In-
cluded in the discussion of adverse effects are the most severe acute reac-
tions and resultant chronic debilitating conditions that have ever been re-
ported, many false claims (for example, that the polio vaccine actually 
causes polio), and commentary that a state’s police power can be used to 
take children from parents who refuse to immunize their children.112 The 
“Adverse Effects” section also contains a statement that “[o]ne of the most 
compelling arguments that points to vaccines as a cause of immune system 
dysfunction is the dramatic improvement that occurs in these cases follow-
ing homeopathic treatment of the vaccine adverse effects” and that homeo-
pathic treatment “serves to antidote [sic] the adverse effect of the vac-
cine.”113 
Following the “Adverse Effects” section, a final section, entitled “Alter-
native Vaccines” (also in bold text two times the font size of the surround-
ing text), describes how homeopathic alternative vaccines (that homeopaths 
call “nosodes”) produce protection for vaccine-preventable diseases.114 
Neustaedter explains that “[a]lternative vaccines in homeopathic form are 
also available . . . for the prevention of whooping cough, meningitis, diph-
theria, tetanus, polio, and other diseases during childhood.”115 Neustaedter 
also explains that, although “homeopathic preparations have not been 
shown to raise antibody levels,” they provide disease protection on “a deep-
er level than that of antibodies,” admitting that clinical studies have not 
been performed (due to their prohibitive cost).116 
Beside each column of vaccine “information” is a display containing 
links to the website store where consumers may purchase Neustaedter’s 
“ChildLife Immune Support Kit” that contains “carefully researched herbs 
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and minerals known for their broad spectrum anti-infective and immune 
stimulating properties.”117 Neustaedter does not explain how “immune 
stimulation” occurs without antibodies being created by the product. 
Neustaedter’s website provides false and misleading (contrary to fact) in-
formation and omits material facts in an effort to entice consumers to pur-
chase alternative products. Further, it offers a vaccine substitute product for 
sale with the “implied representation that it is fit for the purposes for which 
it is sold,” despite Neustaedter’s admission that the product does not in-
crease immune system antibody levels and, therefore, provides no immune 
protection—a clear “representation, omission, or practice that is likely to 
mislead the consumer.”118 
2. Advertisements must be viewed from “the perspective of a consumer 
acting reasonably in the circumstances.”119 
The FTC considers advertisements from the perspective of a reasonable 
consumer under the circumstances to determine if the “consumer’s interpre-
tation or reaction is reasonable,” based on the “totality of the practice,” not-
ing that the advertiser is not responsible for all conceivable interpretations 
or reactions.120 Indeed, “[a]n advertiser cannot be charged with liability 
with respect to every conceivable misconception, however outlandish, to 
which his representations might be subject among the foolish or feeble-
minded.”121 
Where there can be two interpretations of a single representation, the ad-
vertiser is responsible for the misleading as well as the accurate representa-
tion.122 “The test applied by the [FTC] is whether the interpretation is rea-
sonable in light of the claim.”123 Where an advertisement is targeted at a 
particular group, the FTC evaluates the information from the perspective of 
a reasonable member of that group, considering the “entire mosaic” of the 
material presented.124 The FTC does not, however, consider sporadic puff-
ery or marketing hyperbole to be claims that a reasonable consumer would 
consider binding or require documentation.125 
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In the case of HEALTHY.NET, the intended audience is a group of parents 
who are seeking accurate and reliable information about vaccines—
specifically their efficacy and safety. This group likely includes members 
who are generally not scientifically sophisticated, are concerned about the 
well-being of their children, and are using the Internet because they antici-
pate that health-related websites will provide useful and truthful infor-
mation. 
From the perspective of this group, the information presented by Neu-
staedter on HEALTHY.NET is likely very convincing because it claims to be 
supported by external sources, is written in authoritative language, and ap-
pears to be concerned with the safety of vaccines and the possible harm that 
might befall children who are subjected to vaccination.126 The disad-
vantages and dangers of vaccines are presented as an introduction to alter-
native products that are claimed to be reliably safe (because they contain no 
actual active ingredients).127 A reasonable member of the target group 
would likely conclude that vaccines can be dangerous in permanent and 
debilitating ways, but that homeopathic vaccine alternatives convey the 
same disease protection with complete safety. The FTC would likely de-
termine that the meaning of the advertisement is unambiguous in its likeli-
hood to deceive a susceptible group of consumers. 
Marketers such as Neustaedter may counter that the information provid-
ed—albeit contextually inaccurate and misleading—is factual and that 
omitted information is unimportant because all other information was accu-
rate. They might also contend that many other vaccine information sites are 
available on the internet and consumers are free to read information on oth-
er sites to obtain different viewpoints (although no alternate sites are sug-
gested by Neustaedter’s site), and that many other websites contain the 
same or similar information. This reasoning, however, would not survive a 
reasonable person evaluation because the website is not primarily informa-
tional and uses the information to direct consumers to purchase alternative 
products. Therefore, the Neustaedter website, and others like it, would be 
subject to FTC policy prohibiting deceptive commercial advertising. 
3. The representation, omission, or practice must be “material.”128 
For an advertisement to be deceptive, the representation, omission, or 
practice must materially misrepresent information in a way that is “likely to 
affect a consumer’s choice of or conduct regarding a product,” potentially 
causing injury to the consumer. While the FTC “presumes that express 
claims are material,” advertisers may present “relevant and competent evi-
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dence” in rebuttal.129 Further, the FTC “assume[s] that the willingness of a 
business to promote its products reflects a belief that consumers are inter-
ested in the advertising.”130 This belief in consumer interest is the reason 
advertisers provide information on their websites—to inform consumers in 
a manner that produces advertised product sales. Where “a seller intended 
to make an implied claim, the [FTC] infer[s] materiality.”131 In fact, 
“[w]here an action is based on affirmative claims by the defendant, the FTC 
is not required to show that the claims were made with an intent to deceive; 
claims that are material and misleading violate Sections 5 and 12 of the 
FTC Act even if they were made in good faith.”132 
In the case of HEALTHY.NET, the misrepresented information and omis-
sions of fact are material to an accurate presentation of vaccine information. 
The website focused exclusively on possible adverse effects of vaccination 
while omitting information about how targeted childhood illnesses are pre-
vented by vaccination and that adverse side effects are rare and usually 
mild. Neustaedter also omits critical information about the historical effec-
tiveness of vaccines in prevention of morbidity and mortality from vaccine-
preventable illnesses and the danger faced by unvaccinated children who 
are therefore susceptible to vaccine-preventable illnesses. On the contrary, 
Neustaedter presents homeopathic vaccine substitutes as viable alternatives 
despite his carefully phrased mention that homeopathic substitutes do not 
cause antibody production. Neustaedter explains that “[h]omoeopathic rem-
edies reduce the patient’s sensitivity to the dynamic stimulus of the virus or 
bacteria, thus lessening the patient’s predisposition to being overcome by 
this stimulus.”133 Since the statement’s meaning is indecipherable, yet used 
as an attempt to explain why antibody production is not important, the FTC 
would likely interpret its inclusion in the advertisement as deceptive mis-
representation of the homeopathic vaccine alternative as efficacious—even 
if on a mystical level. 
4. Application of the Policy Statement on Deception 
The FTC has already used the authority of the Policy Statement on De-
ception to restrict false and deceptive advertising.134 In re Nature’s Bounty, 
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Inc., et al., is the final FTC decision against a nutritional supplement com-
pany whose products’ health claims were unsubstantiated and went beyond 
mere puffery and hyperbole to actionable false advertising and misrepresen-
tation.135 Nature’s Bounty was ordered to pay $250,000 in anticipation of 
customer redress and to modify its marketing to eliminate unfounded health 
claims.136 
However, the decision did not truly solve the problem. Because Nature’s 
Bounty was only ordered to stop making such claims in advertising materi-
al, one member of the FTC wrote in her dissent that: 
the order leaves the respondents free to sell products they know, or 
should know, are deceptively labeled. The proviso in paragraph V of the 
order states that the respondents would not necessarily be liable for false or 
unsubstantiated claims appearing on the labels or in the packaging of the 
products sold at its stores, even if it were clear that the companies had actu-
al knowledge that those claims were unsubstantiated or untrue. I believe 
that the order should have provided that the respondents would be liable if 
they know, or should know, that the labels or packaging of any such prod-
uct contains false or unsubstantiated claims.137 
Although a $250,000 payment and considerable restructuring of a com-
pany’s marketing strategy may seem an equitable resolution in this case, the 
relatively lenient consequences likely do not send a clear message either to 
Nature’s Bounty or other profitable nutritional supplement companies. The 
danger to consumers from nutritional supplements is slight in comparison to 
the potential morbidity and mortality facing unvaccinated children. There-
fore, more aggressive and corrective actions should be used to remedy de-
ceptive advertising practices that dissuade parents from vaccinations in 
favor of water with magical properties. The consequences of ineffective 
action are potentially devastating. 
VI. Protecting the Public Health138 
When parents decide not to immunize their children, the harm caused is 
first and foremost to the vaccine deprived children, left unprotected. But the 
threat created by an ever-increasing number of unimmunized children is to 
all consumers.139 While all consumers are free to make choices, those 
choices should be properly informed. Even if a small fraction of the con-
suming public believes in mystical or imaginary powers of water 
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“memory,” those persons’ gullibility140 creates vulnerability in others who 
are not part of their decision-making. Laws exist for the purpose of protect-
ing the most vulnerable. 
A. Regulatory Options 
The Federal Trade Commission Act (FTCA) provides several options for 
redress.141 Injunction, monetary penalties, and criminal sanctions are avail-
able to address deceptive health product marketing.142 
The FTC has the power to enjoin an advertiser from continuing to pub-
lish any advertising that may violate the FTCA, pending resolution of a 
complaint or investigation.143 With a proper showing of proof, injunctive 
relief can be used in anticipation of deceptive advertising if the injunctive 
relief “bear[s] a reasonable relation to the unlawful practices.”144 Such was 
the case in POM Wonderful where an Internet marketer rejected FTC orders 
and refused to provide assurance that it would cease deceptive advertis-
ing.145 In United States Dep’t of Justice v. Daniel Chapter One, after suffi-
cient warning and temporary injunction, a permanent injunction was im-
posed on a commercial advertiser who: 
continued to violate the FTC Order by (1) continuing to make representa-
tions . . . that their products treat or cure cancer without competent and reli-
able scientific evidence to substantiate those representations, (2) encourag-
ing potential customers to visit websites . . . that contain prohibited infor-
mation and endorsements of the prohibited supplements, [and] (3) not re-
moving certain representations from the websites within their control.146 
Injunction can be a powerful disincentive and an effective anticipatory 
remedy. 
Courts have interpreted the FTC’s authority under 15 U.S.C. § 53(b) as 
“not limited to the power to issue an injunction; rather, it includes the ‘au-
thority to grant any ancillary relief necessary to accomplish complete jus-
tice.’”147 “This power includes the power to order restitution . . . under Sec-
tion 13(b) if the FTC shows that the [advertiser] engaged in misrepresenta-
tions or omissions of a kind usually relied on by reasonably prudent persons 
and that consumer injury resulted.”148 Further, “because the FTC Act is 
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designed to protect consumers from economic injuries, courts have often 
awarded the full amount lost or paid by consumers rather than limiting 
damages to a defendant’s profits.”149 In Daniel Chapter One, the FTC pre-
cisely calculated that “the defendants collected $1,345,832.43 from the sale 
of the Products between April 2, 2010, when the FTC’s Order went into 
effect, and May 24, 2012, when the defendants stopped violating the FTC 
Order.”150 
Section 54(a) of the FTCA provides criminal penalties for recalcitrant 
advertisers and particularly egregious violations of Section 52(a).151 The 
FTCA states, in part: 
Any person, partnership, or corporation who violates any provision of 
section 52(a) of this title shall, if the use of the commodity advertised may 
be injurious to health because of results from such use under the conditions 
prescribed in the advertisement thereof, or under such conditions as are 
customary or usual, or if such violation is with intent to defraud or mislead, 
be guilty of a misdemeanor, and upon conviction shall be punished by a 
fine of not more than $5,000 or by imprisonment for not more than six 
months, or by both such fine and imprisonment . . . .152 
Criminal penalties can be more severe for repeated violations. 
Although monetary and criminal sanctions can be effective, they are ac-
tions that are taken after an injury has occurred. Prevention is preferable. 
B. The FDA Should Repeal Compliance Policy Guide, Section 400.400, 
and Enforce Efficacy and Safety Standards for Homeopathic Preparations. 
Inexplicably, “the FDA allows a private organization to designate which 
homeopathic drugs meet certain (and unknown) standards for strength, 
quality, and purity set forth in the HPUS” (Homeopathic Pharmacopeia of 
the United States).153 The Boiron court concluded: 
Unlike non-homeopathic OTC drugs, homeopathic OTC drugs . . . are 
not evaluated by the FDA at all. The FDA defines a homeopathic drug as 
any drug labeled as being homeopathic that is also listed in the HPUS, an 
addendum, or its supplements.154 
. . . 
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The Court is unaware of what standards, if any, exist to ensure that ho-
meopathic OTC drugs are safe and effective. The FDA does not impose 
additional standards for strength, purity, quality, safety, or efficacy on ho-
meopathic OTC remedies. Indeed, the FDA has advised that unless a ho-
meopathic remedy is “being offered for use (or promoted) significantly 
beyond recognized or customary practice of homeopathy,” federal policies 
on health fraud do not apply.155 
. . . 
[The FDA has] largely abdicated any role it might have had in creating 
standards for homeopathic OTC drugs, and has instead attempted to dele-
gate this authority to the non-governmental organization that determines 
whether homeopathic substances should be included in the HPUS. In addi-
tion, the FDA explicitly states that it makes no guarantee about the safety or 
efficacy of homeopathic OTC drugs even if they meet the unknown stand-
ards for inclusion in the HPUS.156 
The FDA should treat homeopathic preparations just as it regulates all 
other OTC health aids. 
The FTC has stated that “competent and reliable scientific evidence shall 
include at least two adequate and well-controlled, double-blinded clinical 
studies which conform to acceptable designs and protocols and are con-
ducted by different persons, each of whom is qualified by training and ex-
perience to conduct such studies, independently of each other.”157 Similarly, 
but less rigorously, the Code of Federal Regulations defines valid scientific 
evidence as “evidence from well-controlled investigations, partially con-
trolled studies, studies and objective trials without matched controls . . . 
reports of significant human experience with a marketed device, from 
which it can fairly and responsibly be concluded by qualified experts that 
there is reasonable assurance of the safety and effectiveness of the de-
vice.”158 
Because the FDA has not reviewed homeopathic products for safety or 
efficacy, the key to imposing standards of safety and efficacy to homeo-
pathic preparations is to repeal CPG, Section 400.400.159 This would allow 
the FDA to hold homeopathic products to standards that would ensure effi-
cacy and bolster consumer confidence. A repeal would also eliminate the 
conflicting standards and loopholes between the FDA and FTC homeo-
pathic regulations. 
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Repealing CPG, Section 400.400, will seem to some to be a dramatic and 
overly broad imposition of regulatory control over an expansive and hereto-
fore independent industry. This sentiment may stem from Congress’s pass-
ing of the initial Food, Drug, and Cosmetic Act of 1938, sponsored by Sen-
ator Royal Copeland, a homeopathic physician who insisted that the Act 
recognize homeopathic preparations.160 Since then, a highly profitable ho-
meopathic industry has grown, proponents have become financially and 
politically powerful, and homeopathic practitioners have amassed a large 
group of supporters. Although the FDA’s path may be arduous, it is aligned 
with the Agency mission to protect the public health. 
C. The FDA and FTC Can and Should Do What Consumers Reasonably 
Cannot. 
Significant barriers would confront an individual considering litigating a 
single episode of commercial deception. Unless a consumer died or sus-
tained serious injury, the most optimistic benefit of litigation is over-
whelmed by the cost of bringing the action. Even if a death were to stimu-
late legal action, the consumer has the burden of proving the information on 
a single website caused the decedent’s demise through the complex ma-
chinery of the tort system. Even for a group of harmed consumers who wish 
to litigate as a class, the legal and financial hurdles would be are daunting. 
In contrast, the burden of litigating in consumers’ interests and for the 
benefit of the consuming public is the mission of the FDA and FTC.161 Alt-
hough their budgets are finite, the financial costs are spread over all mem-
bers of the society, their legal staffs have the knowledge and expertise to 
properly litigate these cases, and their arsenal of remedies includes sanc-
tions unavailable in individual consumer actions. The FDA and FTC can 
prevent or stop a company from marketing or distributing a product if it 
does not perform as it is advertised, and can impose significant monetary 
sanctions and criminal penalties for violations.162 
The most important benefit is that federal regulators can intervene before 
a deceptively advertised product causes harm to vulnerable consumers. Pre-
vention of harm is the greatest benefit of federal intervention. 
VII. Conclusion 
Justice consists not in being neutral between right and wrong, but finding 
out the right and upholding it, wherever found, against the wrong.163 
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The missions of the Food and Drug Administration and the Federal Trade 
Commission involve protecting consumers from deceptive advertising and 
products that present dangers unforeseen to the consuming public. 
Some commercial internet sites falsely claim that vaccinations are inef-
fective, unsafe, and even harmful, while advertising so-called vaccine alter-
natives that are claimed to be completely safe and have the same disease-
preventive qualities as vaccines. Some advertisers present deceptive infor-
mation for the express purpose of generating business for their alternative 
products while dissuading consumers from vaccinations. The result has 
been an increasingly unvaccinated population and ensuing increase in vac-
cine-preventable illnesses. The resultant morbidity and mortality are pre-
ventable and should be addressed by the FDA and FTC as matters of seri-
ous public health matters. 
Unlike the FDA requirements imposed on all other over-the-counter 
preparations, the Compliance Policy Guide, Section 400.400, exempts ho-
meopathic preparations from any efficacy or safety requirement. This poli-
cy inappropriately exposes the consuming public to potential dangers of 
untested products for which the homeopathic industry claims exemption 
under the CPG. 
Although the FTC requires clinical testing of advertised health products, 
homeopathic preparations are exempt under the industry’s claim that their 
products have no pharmacologically active ingredients. In seeming contra-
diction to their advertised claims of medicinal effects, homeopathic market-
ers can truthfully claim their products may be advertised under FTC guide-
lines simply because they are inert. 
This loophole should be closed and deceptive advertisements that entice 
parents to eschew vaccinations in favor of ineffective substitutes should be 
halted. The FTC has the authority to address the deceptive advertising and, 
by repealing CPG, Section 400.400, the FDA has the power to require that 
all health preparations meet the same safety and efficacy requirements. 
